Novel Embolic Device Used for Arterial and Venous Tumor Treatments
GPX Embolic Device Showcased at Leipzig Interventional Course (LINC) for Interventional Oncology Embolizations
News provided by
Share this article
Share this article
SALT LAKE CITY, Feb. 2, 2021 /PRNewswire/ Fluidx Medical Technology announced GPX Embolic Device first patient use cases were presented at the Leipzig Interventional Course (LINC) in Leipzig, Germany (https://linc.live-events.live/on-demand/dq2GmM8LqnsqQJfgc). This is very promising technology, said Andrew Holden, M.D., MBChB, FRANZCR, EBIR, ONZM, Director of Interventional Radiology, Auckland City Hospital, Auckland, New Zealand. The very radiopaque GPX penetrates distally extremely well with excellent control and devascularized the renal tumor entirely.
12-Month Data Presented for MedAllianceâs Selution SLR in BTK Lesions
Created with Sketch.
January 28, 2021 MedAlliance announced that 12-month results from the PRESTIGE below-the-knee (BTK) study were presented as a late-breaking trial at LINC 2021, the Leipzig Interventional Course held as a virtual event January 25-29. The study sought to evaluate the safety and performance of the Selution SLR, the company’s sirolimus-eluting balloon for the treatment of long tibial occlusive lesions (TASC C & D) in patients with critical limb ischemia.
According to the company, PRESTIGE is a prospective, single-center, physician-initiated clinical study conducted by Associate Professor Tze Tec Chong, MD, and Tjun Yip Tang, MD, who are Senior Consultants in the Department of Vascular Surgery at Singapore General Hospital in Singapore.
Philips 3-D Ultrasound Offers New Surveillance Method for Abdominal Aortic Aneurysms
Philips Abdominal Aortic Aneurysm (AAA) Model helps increase diagnostic confidence and improved patient experience compared to current standard of care
The Philips AAA Model integrates software and Philips 3-D ultrasound technologies into a single solution to automatically segment and quantify the size of the aneurysm sac for surveillance of known native and post-EVAR treated AAAs.
January 27, 2021 Philips Healthcare has introduced the Philips Abdominal Aortic Aneurysm (AAA) Model, providing physicians a more patient-friendly solution compared to the current standard of care for managing AAA patients. Based on 3-D ultrasound, Philips AAA Model delivers clinicians accurate diagnostic information without exposing patients to high doses of radiation and nephrotoxic contrast agents.
FLEX Vessel Prep(TM) System Data Presented During Leipzig Interventional Course (LINC) 2021 mesabitribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mesabitribune.com Daily Mail and Mail on Sunday newspapers.